业界动态国内医卫资讯
FDA批准替拉珠单抗用于成人银屑病关节炎
Medscape News · 2026-10-30 23:51
摘要
替拉珠单抗是FDA批准用于银屑病关节炎的第三种IL-23抑制剂。Medscape Medical News
English
FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults
Tildrakizumab is the third IL-23 inhibitor to be approved by the FDA for psoriatic arthritis. Medscape Medical News